Literature DB >> 33757784

Trends in Acute Myocarditis Related Pediatric Hospitalizations in the United States, 2007-2016.

Rhythm Vasudeva1, Parth Bhatt2, Christian Lilje3, Pooja Desai1, Jason Amponsah4, Jacob Umscheid1, Narendrasinh Parmar5, Neel Bhatt6, Reshmi Adupa7, Sukrut Pagad8, Prerna Agrawal9, Keyur Donda10, Fredrick Dapaah-Siakwan11, Priyank Yagnik12.   

Abstract

There has been little exploration of acute myocarditis trends in children despite notable advancements in care over the past decade. We explored trends in pediatric hospitalizations for acute myocarditis from 2007 to 2016 in the United States (US). This was a retrospective, serial cross-sectional study of the National Inpatient Sample database from 2007 to 2016, identifying patients ≤18 years hospitalized with acute myocarditis. Patient demographics and incidence trends were examined. Other relevant clinical and resource utilization outcomes were also explored. Out of 60,390,000 weighted pediatric hospitalizations, 6371 were related to myocarditis. The incidence of myocarditis increased from 0.7 to 0.9 per 100,000 children (p <0.0001) over the study period. The mortality decreased from 7.5% to 6.1% (p = 0.02). A significant inflation-adjusted increase by $4,574 in the median hospitalization cost was noted (p = 0.02) while length of stay remained stable (median 6.1 days). Tachyarrhythmias were identified as the most common type of associated arrhythmia. The occurrence of congestive heart failure remained steady at 27%. In conclusion, in-hospital mortality associated with pediatric acute myocarditis has decreased in the United States over years 2007 to 2016 with a concurrent rise in incidence. Despite steady length of stay, hospitalization costs have increased. Future studies investigating long-term outcomes relating to acute myocarditis are warranted.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33757784     DOI: 10.1016/j.amjcard.2021.03.019

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Comparison of Multisystem Inflammatory Syndrome in Children-Related Myocarditis, Classic Viral Myocarditis, and COVID-19 Vaccine-Related Myocarditis in Children.

Authors:  Trisha Patel; Michael Kelleman; Zachary West; Andrew Peter; Matthew Dove; Arene Butto; Matthew E Oster
Journal:  J Am Heart Assoc       Date:  2022-04-27       Impact factor: 6.106

2.  Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.

Authors:  Matthew E Oster; David K Shay; John R Su; Julianne Gee; C Buddy Creech; Karen R Broder; Kathryn Edwards; Jonathan H Soslow; Jeffrey M Dendy; Elizabeth Schlaudecker; Sean M Lang; Elizabeth D Barnett; Frederick L Ruberg; Michael J Smith; M Jay Campbell; Renato D Lopes; Laurence S Sperling; Jane A Baumblatt; Deborah L Thompson; Paige L Marquez; Penelope Strid; Jared Woo; River Pugsley; Sarah Reagan-Steiner; Frank DeStefano; Tom T Shimabukuro
Journal:  JAMA       Date:  2022-01-25       Impact factor: 157.335

Review 3.  Pediatric Myocarditis: What Have We Learnt So Far?

Authors:  Elettra Pomiato; Marco Alfonso Perrone; Rosalinda Palmieri; Maria Giulia Gagliardi
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-03

4.  Sex Differences in Incidence, Clinical Characteristics and Outcomes in Children and Young Adults Hospitalized for Clinically Suspected Myocarditis in the Last Ten Years-Data from the MYO-PL Nationwide Database.

Authors:  Krzysztof Ozierański; Agata Tymińska; Aleksandra Skwarek; Marcin Kruk; Beata Koń; Jarosław Biliński; Grzegorz Opolski; Marcin Grabowski
Journal:  J Clin Med       Date:  2021-11-24       Impact factor: 4.241

5.  Return to School and COVID-19 Vaccination for Pediatric Solid Organ Transplant Recipients in the United States: Expert Opinion for 2021-2022.

Authors:  Kevin J Downes; Victoria A Statler; Rachel C Orscheln; Melissa K Cousino; Michael Green; Marian G Michaels; William J Muller; Tanvi S Sharma; Lara A Danziger-Isakov; Monica I Ardura
Journal:  J Pediatric Infect Dis Soc       Date:  2022-02-23       Impact factor: 3.164

6.  Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance.

Authors:  Sharifa Nasreen; Andrew Calzavara; Sarah A Buchan; Nisha Thampi; Caitlin Johnson; Sarah E Wilson; Jeffrey C Kwong
Journal:  Vaccine       Date:  2022-04-27       Impact factor: 4.169

7.  COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis.

Authors:  Oscar Hou In Chou; Jonathan Mui; Cheuk To Chung; Danny Radford; Simon Ranjithkumar; Endurance Evbayekha; Ronald Nam; Levent Pay; Danish Iltaf Satti; Sebastian Garcia-Zamora; George Bazoukis; Göksel Çinier; Sharen Lee; Vassilios S Vassiliou; Tong Liu; Gary Tse; Ian Chi Kei Wong; Oscar Hou In Chou; Tong Liu; Gary Tse
Journal:  Clin Res Cardiol       Date:  2022-07-30       Impact factor: 6.138

8.  Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.

Authors:  Julia W Gargano; Megan Wallace; Stephen C Hadler; Gayle Langley; John R Su; Matthew E Oster; Karen R Broder; Julianne Gee; Eric Weintraub; Tom Shimabukuro; Heather M Scobie; Danielle Moulia; Lauri E Markowitz; Melinda Wharton; Veronica V McNally; José R Romero; H Keipp Talbot; Grace M Lee; Matthew F Daley; Sara E Oliver
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-07-09       Impact factor: 17.586

9.  The Burden of COVID-19 in Children and Its Prevention by Vaccination: A Joint Statement of the Israeli Pediatric Association and the Israeli Society for Pediatric Infectious Diseases.

Authors:  Michal Stein; Liat Ashkenazi-Hoffnung; David Greenberg; Ilan Dalal; Gilat Livni; Gil Chapnick; Chen Stein-Zamir; Shai Ashkenazi; Lior Hecht-Sagie; Zachi Grossman
Journal:  Vaccines (Basel)       Date:  2022-01-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.